These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24103034)

  • 1. Two-week wait symptoms are prevalent in screened patients with a positive faecal occult blood test but do not predict cancer.
    Vaughan-Shaw PG; Cutting J; Borley N; Brooklyn T; Wheeler JM
    Colorectal Dis; 2014 Jan; 16(1):40-7. PubMed ID: 24103034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population.
    Ahmed S; Leslie A; Thaha MA; Carey FA; Steele RJ
    Br J Surg; 2005 Apr; 92(4):478-81. PubMed ID: 15609377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms do not predict colorectal cancer in an FOB screened population.
    Saldanha JD; Moug SJ; Linton K; Diament RH
    Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower gastrointestinal symptoms are prevalent among individuals colonoscoped within the Bowel Cancer Screening Programme.
    Rajasekhar PT; Ritchie M; Rutter MD; Clifford G; Waddup G; Dempsey N; Rubin GP; Rees CJ
    Colorectal Dis; 2012 Sep; 14(9):e603-7. PubMed ID: 22554066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonoscopy in symptomatic patients with positive family history of colorectal cancer.
    Charalambopoulos A; Syrigos KN; Ho JL; Murday VA; Leicester RJ
    Anticancer Res; 2000; 20(3B):1991-4. PubMed ID: 10928139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The misuse of the faecal occult blood test under the lower gastrointestinal two week wait rule.
    Shaw AG; Lund JN; Longman C; Tierney GM; Goddard AF
    Colorectal Dis; 2009 Jan; 11(1):94-6. PubMed ID: 18462248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.
    Patel RK; Sayers AE; Seedat S; Altayeb T; Hunter IA
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1408-14. PubMed ID: 25244412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel pathway for investigation of colorectal symptoms with colonoscopy or computed tomography colonography.
    Sanders AD; Stevenson C; Pearson J; Burt M; McGeoch G; Hudson B; Eglinton TW
    N Z Med J; 2013 Sep; 126(1382):45-57. PubMed ID: 24154769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
    Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
    J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
    Alatise OI; Ayandipo OO; Adeyeye A; Seier K; Komolafe AO; Bojuwoye MO; Afuwape OO; Zauber A; Omisore A; Olatoke S; Akere A; Famurewa O; Gonen M; Irabor DO; Kingham TP
    Cancer; 2018 Jul; 124(13):2766-2773. PubMed ID: 29645077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
    Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
    Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings of diagnostic colonoscopy in young adults versus findings of screening colonoscopy in patients aged 50 to 54 years: a comparative study stratified by symptom category.
    Cha JM; Kozarek RA; La Selva D; Gluck M; Ross A; Chiorean M; Koch J; Lin OS
    Gastrointest Endosc; 2015 Jul; 82(1):138-45. PubMed ID: 25843617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic yield of colorectal neoplasia with colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding.
    Neugut AI; Garbowski GC; Waye JD; Forde KA; Treat MR; Tsai JL; Lee WC
    Am J Gastroenterol; 1993 Aug; 88(8):1179-83. PubMed ID: 8338084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms associated with finding colorectal cancer during colonoscopy.
    Pullens HJ; Laheij RJ; Vleggaar FP; van Oijen MG; Siersema PD
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1295-9. PubMed ID: 24081105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis improves survival in colorectal cancer.
    Keane MG; Johnson GJ
    Practitioner; 2012; 256(1753):15-8, 2. PubMed ID: 22988701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.